ProtoLytic

About:

ProtoLytic is a developer of decision support tools for medical cost management.

Website: http://protolytic.com/

Twitter/X: protolytic

Description:

ProtoLytic is a developer of decision support tools for medical cost management. Its decision support system uses statistical and clinical modeling to create a unique Treatment Plan for the patient based on evidence-based guidelines and the interdependencies between related diagnosis and patient demographic data. Currently, case managers and adjusters review all requests for services using their clinical expertise to evaluate need and appropriateness. The ProtoLytic system makes this process more efficient and allows the users to focus on anomalies rather than all requests. The system creates the Treatment Plan for pre-authorization, directs care to client-selected network providers, flags unnecessary utilization, and sets claim reserves. The company started in 1999 and is headquartered in Tampa, Florida.

Total Funding Amount:

$1.51M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Tampa, Florida, United States

Founded Date:

1999-01-01

Contact Email:

contact(AT)protolytic.com

Founders:

Thomas R. Sweet

Number of Employees:

1-10

Last Funding Date:

2022-03-09

IPO Status:

Private

Industries:

© 2025 bioDAO.ai